US 7772366
Inhibitors of interleukin-1β converting enzyme
granted A61KA61K38/00
Quick answer
US patent 7772366 (Inhibitors of interleukin-1β converting enzyme) held by Vertex Pharmaceuticals Incorporated expires Mon Aug 05 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Aug 10 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 05 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K38/00